Evaluation of applying topical tranexamic acid to control septorhinoplasy - induced hemorrhage

Am J Otolaryngol. 2022 Sep-Oct;43(5):103514. doi: 10.1016/j.amjoto.2022.103514. Epub 2022 Jun 4.

Abstract

Objectives: Hemorrhagic events related to surgical field is a common disturbing complication which could worsen the outcomes of operation. This study aimed to evaluate how applying of topical tranexamic acid (TXA) could affect bleeding related to septorhinoplasty operation.

Material and methods: This double-blind controlled trial study finally evaluated 198 candidates for septorhinoplasty repair who were randomly allocated to two groups: TXA receivers (5 mg/kg) and control group (received 5 mg/kg of saline 0.9 %). Then cumulative volume of hemorrhage was calculated by adding total volume of suctioned blood and numbers of fully blood-filled surgical gauzes (15 mL in each). Additionally postoperative 24 h volume of hemorrhage was measured by counting number of bloody surgical gauzes.

Results: Of all participants, 90 % were female. The mean age was 26 ± 7 years. Total cumulative volume of hemorrhage during surgery was significantly diminished when topical TXA was applied (p < 0.0001). Additionally drier field of operation was illustrated postoperatively in patients received topical TXA (2 % & 28 % in TXA and saline 0.9 % receivers, respectively) (p < 0.001).

Conclusion: Using topical TXA could decrease bleeding volume and make surgical field of septorhinoplasty drier either during surgery or postoperatively.

Keywords: Bleeding; Septorhinoplasty; Topical; Tranexamic acid.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Adult
  • Antifibrinolytic Agents* / therapeutic use
  • Blood Loss, Surgical
  • Double-Blind Method
  • Female
  • Hemorrhage
  • Humans
  • Male
  • Postoperative Hemorrhage / etiology
  • Postoperative Hemorrhage / prevention & control
  • Tranexamic Acid*
  • Young Adult

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid